Yuting Zhang

ORCID: 0000-0002-6880-4289 · 5 papers in corpus
nonrandomized-trial 2026
PeerJ ·doi:10.7717/peerj.21000

BACKGROUND: This study aimed to evaluate the efficacy of growth hormone (GH) as an adjuvant treatment for enhancing embryo quantity in patients with poor ovarian response (POR) who previously had no viable embryos in in vitro fertilization …

observational 2025
Journal of ovarian research ·doi:10.1186/s13048-025-01594-6

BACKGROUND: To a large extent, the ovarian reserve determines a woman's reproductive potential. The etiological and pathological mechanisms of diminished ovarian reserve (DOR) remain unclear, and no reliable treatment is currently available…

lab-animal 2024
Molecular human reproduction ·doi:10.1093/molehr/gaae042

Endometrial collagen I undergoes dynamic degradation and remodelling in response to endometrial stromal cell (ESC) decidualization and embryo implantation. However, excessive collagen I deposition in the endometrium during the implantation …

lab-animal 2024
Journal of cellular and molecular medicine ·doi:10.1111/jcmm.70228

Anti-vascular endothelial growth factor (VEGF) drugs suppress choroidal neovascularisation (CNV), thus improving vision. However, some patients may have a poor response or develop resistance to anti-VEGF drugs. Geraniin (GE), a polyphenol i…

2023
·doi:10.2139/ssrn.4325256